Moderna | MRNA - Cost Of Sales

Stock Price
41.01
Daily Change
0.14 0.34%
Monthly
14.27%
Yearly
25.80%
Q1 Forecast
42.71

Moderna reported $207M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Acadia Pharmaceuticals USD 21.65M 913K Sep/2025
Agios Pharmaceuticals USD 1.68M 22K Sep/2025
Alnylam Pharmaceuticals USD 200.15M 57.2M Sep/2025
Amgen USD 1.79B 128M Dec/2025
Biogen USD 810.1M 205.1M Sep/2025
BioMarin Pharmaceutical USD 144.93M 10M Sep/2025
Celltrion KRW 402.86B 14.24B Sep/2025
Cspc Pharmaceutical CNY 2.28B 25.27M Sep/2025
Divis Laboratories Ltd INR 11.86B 1.18B Sep/2025
Gilead Sciences USD 1.57B 68M Sep/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
Incyte USD 99M 20.23M Sep/2025
Ionis Pharmaceuticals USD 2.34M 1.81M Sep/2025
Kangmei Pharma CNY 1.11B 84.66M Sep/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Moderna USD 207M 88M Sep/2025
Organigram Holdings CAD 77.46M 14.63M Sep/2025
Pharma Mar EUR 2.3M 477K Sep/2025
Qiagen NV USD 187.78M 11.47M Sep/2025
Regeneron Pharmaceuticals USD 584.6M 63M Dec/2025
Sarepta Therapeutics USD 151.45M 1.77M Sep/2025
Sartorius EUR 450M 18.1M Sep/2025
Sino Biopharmaceutical CNY 3.08B 589.65M Jun/2025
Tilray USD 164.37M 8.41M Sep/2025
Ultragenyx Pharmaceutical USD 27.99M 4.99M Sep/2025
United Therapeutics USD 100.9M 74.3M Sep/2025
Vertex Pharmaceuticals USD 414.8M 7.3M Sep/2025
Zz Pientze Pharmaceu CNY 1.34B 601.08M Sep/2025